Response to Comment on "The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma" by Niccolo Petrucciani, MD, PhD, FACS, Laura Antolino, MD, Giovanni Moschetta, MD, Giovanni Ramacciato, MD, FACS.

导出原文传递

翻译打印收藏纠错

作者： John P,Neoptolemos ^[1] ; Paula,Ghaneh ; Jörg,Kleeff ; Christopher M,Halloran ; Markus W,Büchler

作者单位： The Department of Surgery, University of Heidelberg, Heidelberg, Germany The Department of Surgery, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK The Department of Surgery, University Hospital Halle, Martin-Luther-University Halle-Wittenberg, Germany The Department of Surgery, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK The Department of Surgery, University of Heidelberg, Heidelberg, Germany. ^[1]

主题词癌, 胰腺管(Carcinoma, Pancreatic Ductal);化学疗法, 辅助(Chemotherapy, Adjuvant);人类(Humans);肿瘤复发, 局部(Neoplasm Recurrence, Local);胰腺肿瘤(Pancreatic Neoplasms)

DOI 10.1097/SLA.0000000000003371

PMID 31090562

发布时间 2024-02-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交